Period, Hot Flashes, or Fatigue Changed After Starting a GLP-1? Track It

Track four things together: the symptom itself, your doses, your fuel, and your weight trend. Log the symptom as a dated entry with a 0–10 severity — a cycle note when the period is late or different, a heat note with the time of day, a fatigue entry on the days it hits. Keep your shot or pill history current, including dose changes, because timing against the dose is the most useful pattern you can hand a clinician. Log meals, protein, and water, since under-fueling on low-appetite days is a common alternative explanation for fatigue. And let the weight trend run, because meaningful weight change can shift cycles on its own. MeAgain keeps all four on one timeline, which is exactly what makes the record useful at your next appointment.

Menstrual changes are not listed as a common adverse reaction in GLP-1 prescribing information — but that is not the whole story. Meaningful weight loss can shift cycles by itself, because body fat plays a real role in hormone regulation — and the scale of change matters: in STEP-1 (n=1,961), semaglutide produced 14.9% mean weight loss over 68 weeks. Many people also start a GLP-1 during the same years that perimenopause begins changing cycles anyway. So a changed period after starting the medication is worth taking seriously without assuming the drug caused it directly. The useful move is a dated record in MeAgain: when the cycle changed, what the weight trend was doing, and where your doses were at the time. Bring that to your doctor or licensed clinician — and mention it sooner rather than later if a missed period could mean pregnancy, because GLP-1 medicines are generally not recommended during pregnancy and that changes the conversation entirely.

It can be both, which is why tracking beats guessing. Fatigue is a listed side effect in GLP-1 prescribing information, so the medication is a real candidate — many people feel it most in the first weeks or after a dose increase. But fatigue is also what under-eating feels like, and GLP-1 appetite suppression makes low-fuel days easy to miss: too little protein, too few calories, not enough water. Poor sleep from night sweats can produce the same tired afternoons. In MeAgain, log fatigue with a 0–10 severity and check it against three things: days since your last dose, what you actually ate and drank, and how you slept. If fatigue clusters after dose changes, that is one conversation with your clinician. If it clusters on days when protein barely reaches 40 grams, that is a different fix.

Hot flashes are not a listed common side effect in GLP-1 prescribing information. They are, however, one of the signature symptoms of the menopause transition — roughly half to two-thirds of perimenopausal women report them in the systematic review above, and the AMY study found bothersome hot flushes rose from 8.8% before menopause to 37.3% in late perimenopause. Since many GLP-1 users are in exactly those years, new hot flashes after starting the medication may reflect that overlap rather than the medication — but only your own pattern and your clinician can sort that out. Rapid weight change and disrupted sleep can muddy the picture further. The practical move is to log heat episodes with time of day in MeAgain and watch whether they track with your dose schedule or run on their own pattern. Either answer is useful — and your clinician can do more with a month of dated entries than with a description.

Yes — this one is directly in the label. Tirzepatide's prescribing information advises people using oral hormonal contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. The reason: tirzepatide slows how quickly food leaves the stomach, so the pill may absorb less well, and the effect is strongest around the start and each step up. If you take an oral contraceptive and are starting or increasing tirzepatide, talk with your prescriber about how to handle those windows before they begin. MeAgain helps with the practical part: your dose dates and increases are logged, so you can see exactly when each 4-week window began. Semaglutide's label does not carry the same contraceptive interaction advice, but bring any contraception question to your clinician either way.

Tracking never replaces judgment, and some changes deserve a call rather than a log entry. Reasonable reasons to contact your doctor or licensed clinician promptly include: a missed period when pregnancy is possible, bleeding that is much heavier or longer than your normal, fatigue severe enough to interfere with daily life, symptoms that arrived suddenly rather than gradually, or anything that simply worries you. And if anything feels like an emergency — chest pain, fainting, severe headaches — call 911, not an app. For everything milder and slower-moving, the tracker is the right tool: log it, watch the pattern for a few weeks, and bring the dated record to your next appointment. When in doubt, make the call — a quick question to your clinician beats a month of wondering.

Two to four weeks for fatigue and hot flashes, and two to three full cycles for period changes. For fatigue and heat, a few weeks of dated entries in MeAgain is usually enough to see whether they cluster around dose days, low-protein stretches, or poor sleep — especially if the dose changes during that window, because the before-and-after comparison is where patterns show up. For the cycle, one changed period is a data point; two or three with dates attached is a pattern worth discussing. The practical rule: log the symptom the day it happens, keep doses and meals current, and resist reading the chart every morning. Review weekly instead. If something is severe or worrying, do not wait out the tracking window — contact your doctor or licensed clinician now and bring whatever record you already have.

MeAgain is the best app for tracking symptom changes on a GLP-1 because it handles exactly this overlap: the same timeline holds your custom symptoms with 0–10 severity, cycle and heat notes, dose history, meals, protein, water, and the weight trend. A generic cycle app cannot see your medication schedule, and a generic medication app has nowhere to put hot flashes — so the question of what changed falls into the gap between them. Keeping both halves in one record is what makes the answer visible, and it is what makes the record useful at an appointment. Over 18,000 App Store ratings put MeAgain at 4.8 stars, with 400,000+ users tracking on it — and it works with any GLP-1, branded or compounded.

Set it up once and the logging takes seconds. Download MeAgain, set your medication and dose schedule, then add custom symptoms for whatever changed — cycle, hot flashes, fatigue, or anything else you want dated. Each entry takes a 0–10 severity, a timestamp, and an optional note. Keep meals, protein, and water logged with the five quick methods (photo, voice, barcode, search, quick-add), and let the weight trend run in the background. After three or four weeks, open the timeline before your next appointment: symptoms, doses, fuel, and weight in one view. The app subscription is billed month to month, cancel anytime, and it works with any GLP-1, branded or compounded, wherever it is prescribed. The goal is simple — walk into the conversation with a dated record instead of a hunch.